Bioventus Inc reports results for the quarter ended in December - Earnings Summary

Bioventus

31/03/2023 13:41

* Bioventus Inc  BVS.OQ  reported a quarterly adjusted loss
of 6
cents​​ per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for earnings of
5 cents per share.
    * Revenue fell 3.5% to $125.83 million from a year ago;
analysts
expected $132.70 million. 
    * Bioventus Inc's reported EPS for the quarter was a loss
of 52
cents​.
    * The mean earnings estimate of analysts had fallen by
about 12%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Bioventus Inc shares had fallen by 53.6% this quarter.
    * The company reported a quarterly loss of $31.93 million.
    * Wall Street's median 12-month price target for Bioventus
Inc is
$6.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 31 at 12:41 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.05           -0.06          Missed
 Sep. 30 2022      0.12           0.08           Missed
 Jun. 30 2022      0.16           0.10           Missed
 Mar. 31 2022      0.05           0.04           Missed